Immunocore Holdings IMCR
NASDAQ IMCR
$36.13 -1.44 (-3.85%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immunocore Holdings (IMCR) Net Margin (QoQ) (2021 - 2026)

Analysis

Immunocore Holdings (IMCR) Net Margin (QoQ) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Immunocore Holdings 1.85 Bn 965.54 Mn 114.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,286.00
Mar 31, 2026 4,093.00
Dec 31, 2025 -2,858.00
Sep 30, 2025 1,033.00
Jun 30, 2025 -1,582.00
Mar 31, 2025 3,359.00
Dec 31, 2024 -3,917.00
Sep 30, 2024 2,631.00
Jun 30, 2024 1,930.00
Mar 31, 2024 -660.00
Dec 31, 2023 -2,952.00
Sep 30, 2023 3,088.00
Jun 30, 2023 612.00
Mar 31, 2023 1,684.00
Dec 31, 2022 -6,756.00
Sep 30, 2022 6,396.00
Dec 31, 2021 -8,876.00